Edition:
United Kingdom

Heat Biologics Inc (HTBX.OQ)

HTBX.OQ on NASDAQ Stock Exchange Capital Market

2.35USD
4:54pm BST
Change (% chg)

$-0.11 (-4.47%)
Prev Close
$2.46
Open
$2.45
Day's High
$2.45
Day's Low
$2.35
Volume
45,012
Avg. Vol
242,644
52-wk High
$7.85
52-wk Low
$1.09

Latest Key Developments (Source: Significant Developments)

Heat Biologics Says Receives FDA Guidance At Type C Meeting For HS-110 Clinical Trial
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Heat Biologics Inc ::SAYS RECEIVES FDA GUIDANCE AT TYPE C MEETING FOR HS-110 CLINICAL TRIAL.HEAT BIOLOGICS - RECEIVED WRITTEN RESPONSES FROM U.S. FDA REGARDING HS-110 TRIAL DESIGN FOR TREATMENT OF NON-SMALL CELL LUNG CANCER.HEAT BIOLOGICS - FDA AGREED THAT TRIAL DESIGNS, BOTH SINGLE-ARM AND CONTROLLED, WOULD BE APPROPRIATE TO SUPPORT REGISTRATIONAL TRIAL OF HS-110.HEAT BIOLOGICS - TRIAL DESIGN DETAILS AND NEXT STEPS EXPECTED TO BE ANNOUNCED FOLLOWING READ-OUT OF PHASE 2 DATA, ANTICIPATED IN 2H 2018.  Full Article

Heat Biologics reports Q3 net loss attributable to Heat $0.06 per basic and diluted share‍​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Heat Biologics Inc :Heat Biologics Inc - qtrly net loss attributable to Heat for the third quarter of 2017 was $0.06 per basic and diluted share‍​.Heat Biologics Inc - ‍cash and cash equivalents totaled approximately $4.3 million, as of September 30, 2017​.  Full Article

Heat Biologics Inc files for mixed shelf of up to $50 million ‍​
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Heat Biologics Inc :Heat Biologics Inc files for mixed shelf of up to $50 million – SEC filing ‍​.  Full Article

Heat Biologics substantially reduces debt and reports proceeds of approximately $2.8 million
Friday, 7 Oct 2016 

Heat Biologics Inc : Heat Biologics substantially reduces debt and reports proceeds of approximately $2.8 million year to-date from the exercise of warrants .Says that it has paid down $1.5 million on its commercial loan following recent exercise of warrants.  Full Article

Heat Biologics qtrly loss per share $0.17
Monday, 15 Aug 2016 

Heat Biologics Inc : Heat biologics provides corporate update and reports second quarter 2016 financial results .Qtrly loss per share $0.17.  Full Article

Heat Biologics announces proposed public offering of common stock
Thursday, 21 Jul 2016 

Heat Biologics Inc :Announces proposed public offering of common stock.  Full Article

BRIEF-Heat Biologics Files For Offering Of Up To $15 Mln Of Its Common Stock

* FILES FOR OFFERING OF UP TO $15 MILLION OF ITS COMMON STOCK - SEC FILING Source text for Eikon: (http://bit.ly/2GFwyfW) Further company coverage: